Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide
Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerable dose of the
combination of Grifola frondosa extract, azacitidine, and lenalidomide that can be given to
patients with advanced cancer. The safety of this drug combination will also be studied.